Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             30 results found
no title author magazine year volume issue page(s) type
1 Age-Adjusted Reference Values for Prostate Specific Antigen – A Systematic Review and Meta-Analysis Matti, Bashar

20 2 p. e114-e125
article
2 A Serendipitous Preoperative Trial of Combined Ipilimumab Plus Nivolumab for Localized Prostate Cancer van Dorp, Jeroen

20 2 p. e173-e179
article
3 Association Between Preoperative De Ritis (AST/ALT) Ratio and Oncological Outcomes Following Radical Cystectomy in Patients With Urothelial Bladder Cancer Ghahari, Mohammadreza

20 2 p. e89-e93
article
4 Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder Kosiba, Marina

20 2 p. 195.e1-195.e8
article
5 Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs Del Giudice, Francesco

20 2 p. 198.e1-198.e9
article
6 Editorial Board
20 2 p. A1
article
7 Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy Abuhelwa, Ahmad Y.

20 2 p. 132-138
article
8 Establishing metastatic prostate cancer quality indicators using a modified Delphi approach Zheng, Jia

20 2 p. e151-e157
article
9 Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients’ Voice or a Missed Opportunity Chadha, Juskaran

20 2 p. e158-e165
article
10 Extreme Responses to a Combination of DNA-Damaging Therapy and Immunotherapy in CDK12-Altered Metastatic Castration-Resistant Prostate Cancer: A Potential Therapeutic Vulnerability Gongora, Aline B.L.

20 2 p. 183-188
article
11 Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma Adibi, Mehrad

20 2 p. 176-182
article
12 Gender and Age Differences of Genitourinary Cancers Among Chronic Dialysis Patients in Taiwan Tang, Chao‐Hsiun

20 2 p. e126-e134
article
13 Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice Giri, Veda N.

20 2 p. e104-e113
article
14 Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis Ferro, Matteo

20 2 p. e166-e172
article
15 Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis Rodriguez-Vida, Alejo

20 2 p. 197.e1-197.e10
article
16 Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database Fu, Melinda

20 2 p. e135-e139
article
17 Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies Grivas, Petros

20 2 p. 114-122
article
18 Molecular and Clinical Characterization of Patients With Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy Markowski, Mark C.

20 2 p. 97-101
article
19 Neutrophil-to-Lymphocyte Ratio Predicts Cancer Outcome in Locally Advanced Clear Renal Cell Carcinoma Cordeiro, Mauricio Dener

20 2 p. 102-106
article
20 Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma Laymon, Mahmoud

20 2 p. 148-154
article
21 Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer Andruska, Neal

20 2 p. 123-131
article
22 Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series Jindal, Tanya

20 2 p. 189-194
article
23 Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin Talukder, Rafee

20 2 p. 165-175
article
24 Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma Miyake, Makito

20 2 p. 196.e1-196.e9
article
25 Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study Raggi, Daniele

20 2 p. 155-164
article
26 Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes Diamantopoulos, Leonidas N.

20 2 p. 139-147
article
27 Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer Venkat, Siv

20 2 p. e140-e150
article
28 Table of contents
20 2 p. A3-A7
article
29 Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern Era Stewart, Glenn A.

20 2 p. 107-113
article
30 Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer Xiang, Michael

20 2 p. e94-e103
article
                             30 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands